Compare AbCellera Biologics Inc (ABCL) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? AbCellera Biologics Inc trades at $9.06 (market cap $2.99B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: AbCellera Biologics Inc is far larger — about 5.9× Ginkgo Bioworks Holdings Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | DNA | |
|---|---|---|
Market Cap | $2.99B | $505.73M |
Sector | Health | Health |
52-Week High | $9.76 | $16.14 |
52-Week Low | $2.78 | $5.48 |
Enterprise Value | $2.58B | $607.68M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
